Literature DB >> 6123998

Activation of purified soluble guanylate cyclase by protoporphyrin IX.

L J Ignarro, K S Wood, M S Wolin.   

Abstract

Soluble guanylate cyclase [GTP pyrophosphate-lyase (cyclizing), EC 4.6.1.2] purified from bovine lung is markedly activated (30- to 40-fold) by protoporphyrin IX (Ka, 15-25 nM) and is inhibited by hematin (Ki, 3.7 microM) when MgGTP is used as substrate. Guanylate cyclase possesses specific activities (mumol of cGMP per min/mg of protein) of 0.1-0.2 (MgGTP) and 0.3-0.5 (MnGTP) and can attain values of 2-8 (MgGTP) or 1-1.4 (MnGTP) in the presence of protoporphyrin IX. Guanylate cyclase purified in this study contains heme and is activated by nitric oxide and nitrosyl-heme to the same magnitude as that by protoporphyrin IX. With the exception of hematoporphyrin IX, close structural analogs of protoporphyrin IX, including precursors and metabolites, do not activate guanylate cyclase. The insertion of iron into protoporphyrin IX to form heme or hematin renders the metalloporphyrin an inhibitor of unactivated or activated guanylate cyclase. The data suggest that protoporphyrin IX and heme could function to modulate guanylate cyclase activity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6123998      PMCID: PMC346308          DOI: 10.1073/pnas.79.9.2870

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Effects of stimulant and relaxant drugs on tension and cyclic nucleotide levels in canine femoral artery.

Authors:  J Diamond; K S Blisard
Journal:  Mol Pharmacol       Date:  1976-07       Impact factor: 4.436

2.  Structural basis for the conformational states of nitrosyl hemoglobins M Saskatoon and M Milwaukee. Influence of distal histidine residues on proximal histidine-iron bonds.

Authors:  M E John; M R Waterman
Journal:  J Biol Chem       Date:  1980-05-25       Impact factor: 5.157

Review 3.  Effects of sodium nitroprusside and other smooth muscle relaxants on cyclic GMP formation in smooth muscle and platelets.

Authors:  E Böhme; H Graf; G Schultz
Journal:  Adv Cyclic Nucleotide Res       Date:  1978

4.  Increases in cyclic GMP levels in brain and liver with sodium azide an activator of guanylate cyclase.

Authors:  H Kimura; C K Mittal; F Murad
Journal:  Nature       Date:  1975-10-23       Impact factor: 49.962

5.  Restoration of the responsiveness of purified guanylate cyclase to nitrosoguanidine, nitric oxide, and related activators by heme and hemeproteins. Evidence for involvement of the paramagnetic nitrosyl-heme complex in enzyme activation.

Authors:  P A Craven; F R DeRubertis
Journal:  J Biol Chem       Date:  1978-12-10       Impact factor: 5.157

6.  Calcium-independent modulation of cyclic GMP and activation of guanylate cyclase by nitrosamines.

Authors:  F R DeRubertis; P A Craven
Journal:  Science       Date:  1976-09-03       Impact factor: 47.728

7.  Evidence that regulation of hepatic guanylate cyclase activity involves interactions between catalytic site -SH groups and both substrate and activator.

Authors:  L J Ignarro; P J Kadowitz; W H Baricos
Journal:  Arch Biochem Biophys       Date:  1981-04-15       Impact factor: 4.013

8.  Purification of a soluble, sodium-nitroprusside-stimulated guanylate cyclase from bovine lung.

Authors:  R Gerzer; F Hofmann; G Schultz
Journal:  Eur J Biochem       Date:  1981-06-01

9.  Platelet inhibition by sodium nitroprusside, a smooth muscle inhibitor.

Authors:  A Saxon; H E Kattlove
Journal:  Blood       Date:  1976-06       Impact factor: 22.113

10.  Relationship between cyclic guanosine 3':5'-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin.

Authors:  C A Gruetter; D Y Gruetter; J E Lyon; P J Kadowitz; L J Ignarro
Journal:  J Pharmacol Exp Ther       Date:  1981-10       Impact factor: 4.030

View more
  45 in total

1.  Methemoglobin is a supplement for in vitro culture of human nasopharyngeal epithelial cells transformed by human papillomavirus type 16 DNA.

Authors:  W N Wen
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001 Nov-Dec       Impact factor: 2.416

2.  On the activation of soluble guanylyl cyclase by nitric oxide.

Authors:  Tomas C Bellamy; John Wood; John Garthwaite
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

Review 3.  Isoforms of NO-sensitive guanylyl cyclase.

Authors:  Michael Russwurm; Doris Koesling
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

Review 4.  Targeting soluble guanylate cyclase for the treatment of pulmonary hypertension.

Authors:  George F Lasker; Jason H Maley; Edward A Pankey; Philip J Kadowitz
Journal:  Expert Rev Respir Med       Date:  2011-04       Impact factor: 3.772

5.  Crystal structure of an oxygen-binding heme domain related to soluble guanylate cyclases.

Authors:  Patricia Pellicena; David S Karow; Elizabeth M Boon; Michael A Marletta; John Kuriyan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

Review 6.  cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.

Authors:  Sharron H Francis; Jennifer L Busch; Jackie D Corbin; David Sibley
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

7.  NO activation of guanylyl cyclase.

Authors:  Michael Russwurm; Doris Koesling
Journal:  EMBO J       Date:  2004-10-28       Impact factor: 11.598

Review 8.  NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential.

Authors:  Oleg V Evgenov; Pál Pacher; Peter M Schmidt; György Haskó; Harald H H W Schmidt; Johannes-Peter Stasch
Journal:  Nat Rev Drug Discov       Date:  2006-09       Impact factor: 84.694

9.  Aspartate 102 in the heme domain of soluble guanylyl cyclase has a key role in NO activation.

Authors:  Padmamalini Baskaran; Erin J Heckler; Focco van den Akker; Annie Beuve
Journal:  Biochemistry       Date:  2011-05-02       Impact factor: 3.162

10.  Modulation of the NO trans effect in heme proteins: implications for the activation of soluble guanylate cyclase.

Authors:  Marcelo A Martí; Damián A Scherlis; Fabio A Doctorovich; Pablo Ordejón; Darío A Estrin
Journal:  J Biol Inorg Chem       Date:  2003-03-18       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.